Integra lifesciences holdings corp (IART)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10
OPERATING ACTIVITIES:
Net Income (Loss) Attributable to Parent

9,180

15,319

-27,610

29,736

32,756

25,138

13,295

11,376

10,992

44,355

3,158

10,836

6,394

28,248

20,143

12,754

13,419

14,980

-31,881

4,998

8,384

17,166

9,807

4,825

2,206

13,771

-30,330

1,520

-6,028

12,786

13,211

8,514

6,693

4,560

11,243

699

11,487

18,807

16,483

15,157

15,222

Adjustments to reconcile net income to net cash provided by operating activities:
Loss from discontinued operations, net of tax

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-7,022

-3,348

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

29,151

27,878

27,599

26,892

27,093

27,677

29,051

26,906

27,096

26,664

20,969

21,595

19,717

18,312

18,086

18,014

18,253

18,267

16,234

12,562

11,800

12,392

4,878

15,203

13,961

-4,682

11,670

12,636

11,389

13,489

13,314

13,232

12,576

12,869

12,852

14,493

9,958

10,504

9,714

9,523

9,431

Non-cash impairment charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

190

0

0

600

-46,398

46,738

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income tax benefit/provision

5,068

-8,510

-1,459

-2,234

-6,843

-8,973

1,212

1,213

-1,636

-66,369

203

-1,145

7

-3,555

-2,277

-522

-120

-32,929

31,013

224

1,341

-6,760

414

-2,066

1,563

5,897

-6,838

655

-1,055

4,721

-630

-1,571

-983

5,606

759

-3,228

-1,981

5,792

-1,289

-6

-369

Share-based compensation

3,750

5,511

5,885

5,776

4,083

4,993

5,572

5,483

4,731

5,191

5,309

5,687

5,363

4,537

4,876

4,632

3,265

3,662

6,369

3,131

2,288

3,320

2,932

5,831

2,471

2,248

2,830

2,692

2,072

2,419

2,277

2,285

2,070

7,908

3,034

11,829

4,034

5,756

3,933

3,677

3,843

Amortization of debt issuance costs and expenses associated with debt refinancing

4,246

-

-

-

1,357

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

-

-

-

-

-

1,317

1,296

2,138

1,519

1,544

394

391

393

906

387

620

616

619

585

530

530

511

817

635

608

591

613

549

545

622

623

720

760

757

792

1,321

517

425

391

317

357

Non-cash lease expense

2,529

-

-

-

0

-

-

-

-

-

-

-

-

1,774

2,132

2,104

2,064

2,037

2,130

1,885

1,859

1,848

1,823

1,767

1,666

1,598

1,633

1,622

1,610

236

1,788

2,968

3,528

3,472

3,487

1,998

1,634

1,606

1,578

1,888

2,053

Loss on disposal of property and equipment

-374

-977

-233

-244

-367

-416

-842

19

-146

-6,546

9

-104

-348

-719

138

-1,123

-61

-357

-86

-57

19

-404

-127

-378

0

-149

15

34

-1,865

-505

-376

-431

0

-

-

-

-

163

284

-293

-154

Change in fair value of contingent consideration and others

-1,051

1,109

0

-184

194

0

300

535

379

-1,937

-778

-2,256

261

-94

-170

120

131

-182

120

114

125

1,642

120

-1,126

128

-

-

-

-

-

-

-

-277

-

-

-

-

-

-

-

-

Changes in assets and liabilities:
Excess tax benefits from stock-based compensation arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,121

-

43

623

541

130

38

79

23

3,202

14

415

3

4

66

725

53

105

1

562

2,912

Changes in assets and liabilities, net of business acquisitions:
Accounts receivable

-28,301

-8,091

-12,837

16,651

13,705

18,201

-9,600

-9,980

18,400

79,837

-1,442

10,714

589

9,418

-5,425

-4,915

18,440

7,025

4,014

5,746

-554

4,736

12,515

5,565

-5,671

430

-2,185

2,854

-2,109

-5,116

3,585

2,548

-4,800

1,101

76

1,797

-1,096

-474

6,944

591

-3,278

Inventories

26,236

12,755

8,995

9,510

12,048

-11,741

-155

4,893

-1,297

-961

-4,602

257

5,207

515

1,699

-742

8,104

-4,246

1,887

1,254

4,864

347

6,424

8,851

8,516

-1,401

9,367

12,659

6,739

1,791

-3,235

1,302

853

-8,490

-2,762

4,780

4,770

-1,029

649

5,555

2,199

Prepaid expenses and other current assets

-4,683

-21,233

-6,644

1,857

12,949

-501

-5,391

14,122

-12,163

19,117

5,455

7,248

1,988

-13,861

3,311

-3,074

-1,288

7,656

-6,520

3,926

-4,829

-4,960

-14,398

1,250

1,582

-2,690

-600

3,998

-2,704

11,215

-484

-6,045

-1,619

-151

1,738

1,679

-2,871

10,556

-7,981

3,056

821

Other non-current assets

-3,000

-6,506

-3,804

-3,474

628

-2,449

961

775

-339

-1,063

166

1,490

321

-77

-19

-30

601

614

-3,030

1,238

568

8,711

357

1,719

127

-2,387

147

253

115

-324

1

724

152

-436

-64

210

-85

-30

411

-6

-196

Accounts payable, accrued expenses and other current liabilities

-40,235

14,300

-16,044

11,023

5,387

-5,830

12,823

-6,379

2,974

71,300

3,734

10,098

10,189

-6,245

3,594

-9,820

12,057

-7,585

-8,158

28,298

-4,347

-3,717

-320

9,286

-4,438

-12,851

11,292

3,408

-515

-27,599

-850

5,257

2,121

-7,657

-8,609

7,221

-2,797

-5,613

6,308

2,845

3,196

Contract liabilities

338

788

576

-1,783

-188

1,615

-20

-91

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,129

983

1,527

321

620

-36

-769

49

881

167

21

-289

708

-113

391

-138

-624

245

-534

920

292

-480

-628

110

148

-259

-456

Other non-current liabilities

-2,284

-2,656

-489

-3,522

4,608

-155

-4,246

4,861

-69

21,361

9,227

-1,100

-5,685

838

829

-690

-386

1,017

-772

-821

1,521

872

-2,277

-515

-2,437

2,423

-726

-174

-364

324

-1,695

33

399

-1,876

-1,001

-79

-198

-

-

-

-

Net cash provided by operating activities of continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25,640

19,611

46,921

24,891

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-18,937

6,728

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-7,312

2,280

-2,836

Net cash provided by operating activities

20,814

89,184

64,241

48,524

29,484

42,688

79,251

36,213

41,531

11,549

45,242

28,871

28,882

6,529

46,767

38,079

25,030

25,640

19,611

27,984

31,619

24,859

31,075

16,377

11,254

11,696

30,808

2,918

7,846

-3,403

27,909

2,276

32,318

34,695

23,795

24,583

21,255

28,430

29,646

19,358

28,137

INVESTING ACTIVITIES:
Purchases of property and equipment

16,519

22,194

13,593

17,664

16,086

25,685

16,669

20,000

15,387

13,697

7,796

12,819

9,191

21,192

6,974

8,267

10,895

13,099

5,361

9,623

5,330

11,232

6,417

9,356

11,335

4,579

13,247

13,622

10,853

24,672

19,717

14,230

10,412

13,044

12,243

7,216

5,922

18,241

7,206

17,635

-5,944

Cash used in business acquisitions, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-225

0

0

0

-

-

-

-

85,921

0

0

235,000

0

150

64

2,766

5,101

-690

2,692

175

-

-

-

-

-

-

-

-

Acquired in-process research and development

5,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,330

0

0

4,165

4,087

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of short-term investments

-

-

-

-

-

-

-

-

-

0

0

-6,975

-9,976

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from note receivable

0

0

257

250

245

231

233

225

221

0

483

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of property and equipment

34

1

1

0

35

124

93

57

148

136

14

143

0

-

-

-

-

0

0

0

1,438

0

0

0

0

2

3

-2

532

0

0

0

0

-

-

-

-

-

-

-

-

Cash provided by (used in) business acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-193,928

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash provided by business acquisitions

-

-

-

-

-

-

-

20,984

5,720

-

-

-

-

-

-

-

-

-

-1,831

0

1,831

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

14,659

53,248

-

-

-

-

-

-

-

-

Net cash used in investing activities of continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-37,818

-315,448

-9,623

-2,061

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-3,489

-3,571

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from working capital purchase price adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing activities

-21,485

-20,609

-108,839

-17,414

-15,806

-25,330

-16,343

1,266

-9,298

-983,568

-7,107

-37,517

-193,143

-21,142

-6,707

-8,043

-6,730

-37,818

-315,448

-13,112

-5,632

-98,851

-8,775

-9,356

-246,335

-10,127

-13,394

-13,688

-13,087

-29,773

19,855

-5,523

-63,835

-15,575

-80,864

-88,015

-5,922

-

-

-

-

FINANCING ACTIVITIES:
Proceeds from borrowings of long-term indebtedness

113,200

21,100

114,600

34,000

67,200

121,200

0

25,000

25,000

735,617

326,383

35,000

210,000

665,000

0

0

15,000

0

510,000

35,000

0

40,000

150,000

0

235,000

0

10,000

20,000

0

-

-

-

-

-

-

-

-

-

-

-

-

Payments on debt

344,200

102,850

38,250

47,600

57,400

200,000

45,000

380,000

35,000

52,000

35,000

10,000

20,000

462,500

20,000

26,875

1,875

16,875

433,750

0

15,000

35,000

160,000

0

0

-

-

-

-

0

0

-1

12,813

22,812

1,875

146,875

41,875

1,875

0

0

15,000

Purchase of option hedge on convertible notes

104,248

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of capital lease obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

166

164

163

160

156

157

218

178

235

125

123

122

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from Convertible Debt

575,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of stock purchase warrants

44,562

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of debt issuance costs

20,264

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash paid for contingent consideration

-

-

-

-

-

-

0

26,071

7,772

-

4,748

-87

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of treasury stock

100,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14,452

12,002

52,689

4,320

-

-

-

-

Proceeds from exercised stock options

2,303

0

4,735

463

1,750

153

5,512

65

3,662

0

0

8,607

1,167

556

665

8,222

1,038

0

0

7,114

231

6,898

0

562

7,755

1,924

186

0

234

0

446

0

250

153

247

1,610

1,687

10,444

1,069

2,009

2,624

Cash taxes paid in net equity settlement

4,348

242

60

55

6,157

406

175

14,016

-6,776

13,886

-265

-370

-6,128

-284

-298

-218

-4,051

-134

-87

-7,480

1,121

-3,925

43

623

541

130

38

79

23

3,202

14

415

3

4

66

725

53

105

1

562

2,912

Net cash provided by financing activities

162,005

-81,992

81,025

-13,192

5,393

-84,055

-39,839

-36,092

-20,886

664,214

286,370

33,324

185,039

13,763

-19,797

-19,034

9,952

-17,760

245,312

34,416

-13,826

7,638

-13,192

1,062

243,174

-488

184

19,066

257

2,817

460

21,033

-12,560

-27,107

36,377

95,322

-44,455

38,674

-37,004

6,220

-9,464

Effect of exchange rate changes on cash and cash equivalents

-2,533

4,347

-4,530

1,141

-884

-456

-849

-7,012

3,114

797

2,838

5,809

1,280

-4,693

532

-1,285

702

-1,501

-1,201

2,138

-4,284

-1,883

-6,037

39

331

665

2,634

649

-2,263

1,579

2,024

-958

1,911

-2,196

-5,596

1,035

4,713

-1,925

5,528

-5,466

-2,946

Net increase in cash and cash equivalents

158,801

-9,070

31,897

19,059

18,187

-67,153

22,220

-5,625

14,461

-307,008

327,343

30,487

22,058

-5,543

20,795

9,717

28,954

-31,439

-51,726

51,426

7,877

-68,237

3,071

8,122

8,424

1,746

20,232

8,945

-7,247

-28,780

50,248

16,828

-42,166

-10,183

-26,288

32,925

-24,409

45,931

-10,786

11,944

9,783